Commentary
The methodology used in this study is refreshing because UPPP results are usually reported as being successful when AHI is reduced by 50%. This is only meaningful in mild cases, as the authors reported in the article.`Curative' value would be an AHI 510, AI 55 or AHI 510 without excessive daytime somnolence. These are definitions of the disease and treatment such that it is eliminated.
The reported cases are all relatively mild. Commonly in clinical practice patients are treated when there is an AHI 440. Since there is evidence 1 that an AI of at least 20 is associated with significant mortality, halving a rate of 45 would not improve life expectancy.
Importantly, this article demonstrates the futility in trying to determine a site of obstruction, at least using fibreoptic pharyngoscopy with the Mu Èller Manoevre (FPMMM). Presumably the mandibular advancement dental appliance described would have its effect at the level of the hypopharynx, yet most of the group treated this way demonstrated a Fujita type I (oropharyngeal) obstruction. Clinically, attempts to determine the site of obstruction (eg, 3-D CAT or ultra-fast MRI) may be more costly and less effective than a trial using an adjustable mandibular adjustment device (MAD) and a polysomnogram.
Many nonadjustable MADs have been used effectively.
2,3 In recent years, however, clinicians have also used MADs with an adjustable amount of protrusion. The``50% of maximum protrusion'' used in the study device may be ideal for some patients but not for others. Other clinical techniques may give a more ideal fixed position 4 , but with many clinicians now using adjustable MADs, the devices are titrated to an effective protrusion for the individual patient. 
